Applications of nanotechnology in various spheres have increased manifold as it offers
solution to unsolved problems with higher effectiveness. Nanoemulsions are one such …

Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …

The blood–brain barrier (BBB) restricts the transport of potential therapeutic moieties to the
brain. Direct targeting the brain via olfactory and trigeminal neural pathways by passing the …

The blood–brain barrier (BBB) plays a fundamental role in protecting the brain from toxic
substances and therefore also controls and restricts the entry of therapeutic agents. The …

Over the recent couple of decades, pharmaceutical field has embarked most phenomenal
noteworthy achievements in the field of medications as well as drug delivery. The rise of …

Nose-to-brain drug delivery has been of great interest for the treatment of many central
nervous system (CNS) diseases and psychiatric disorders over past decades. Several …

The treatment of neurodegenerative and psychiatric disorders remains a challenge in
medical research. Several strategies have been developed over the years, either to …

Epilepsy is the fourth most common global neurological problem, which can be considered a
spectrum disorder because of its various causes, seizure types, its ability to vary in severity …

Preparation and evaluation of a non-invasive intranasal luteolin delivery for the
management of cognitive dysfunction in Alzheimer's disease (AD) using novel chitosan …

Epilepsy is a common chronic neurological disorder caused by aberrant neuronal electrical
activity. Antiseizure medications (ASMs) are the first line of treatment for people with …